Date published: 2025-12-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

EP1 Inhibitors

EP1 inhibitors constitute a class of small molecules specifically designed to modulate the activity of the prostaglandin E2 receptor subtype 1 (EP1). These compounds exert their effects through direct inhibition of the EP1 receptor or indirectly by influencing signaling pathways associated with EP1 activation. Selective EP1 antagonists, such as sc-51089 and ONO-8713, directly block EP1 activation by competitively binding to the receptor and preventing its interaction with prostaglandin E2 (PGE2). This interference disrupts downstream signaling cascades initiated by EP1, leading to the modulation of cellular responses, including inflammation and pain. Other EP1 inhibitors, such as TG6-10-1 and ONO-AE3-208, share the common mechanism of direct inhibition by competing with PGE2 for binding to EP1. The specificity of these compounds for EP1 allows for a focused exploration of the distinct roles of this receptor in various physiological processes, from vasoconstriction to smooth muscle contraction. Additionally, non-selective EP antagonists like AH 6809 impact EP1 along with other EP receptors, offering researchers the opportunity to assess the collective influence of EP receptor inhibition on diverse physiological and pathological processes. The biochemical and cellular impact of EP1 inhibitors is grounded in their ability to disrupt specific signaling pathways associated with EP1. For instance, sc-19220 directly inhibits EP1 and interferes with downstream cascades, influencing smooth muscle contraction and inflammation. Similarly, MK-7246 and L-798106 specifically target EP1, modulating cellular responses related to vascular tone and inflammation. These compounds serve as valuable tools for researchers aiming to dissect the intricate roles of EP1 in different cellular contexts. In conclusion, EP1 inhibitors represent a diverse class of compounds that either directly block EP1 receptor activation or indirectly modulate signaling pathways associated with EP1. The specificity of these inhibitors allows for a targeted investigation into the physiological and pathological roles of EP1 in various cellular processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

AH-6809

33458-93-4sc-201342
sc-201342A
5 mg
25 mg
$70.00
$282.00
2
(1)

AH-6809, classified as an EP1, showcases intriguing reactivity patterns attributed to its unique acid halide characteristics. The compound engages in selective acylation reactions, driven by its electrophilic nature, which enhances its interaction with nucleophiles. Its structural features enable the formation of transient intermediates, influencing the reaction kinetics significantly. Additionally, AH-6809's polar functional groups contribute to solubility variations, affecting its behavior in diverse chemical environments.

SC51089

146033-02-5sc-201344
sc-201344A
5 mg
25 mg
$59.00
$310.00
(0)

SC51089, an EP1 compound, exhibits remarkable reactivity due to its acid halide functionality. Its electrophilic carbonyl carbon facilitates rapid acyl transfer reactions, allowing for efficient interactions with various nucleophiles. The compound's unique steric and electronic properties lead to distinct regioselectivity in reactions, while its ability to form stable complexes with Lewis bases enhances its reactivity profile. Furthermore, SC51089's solvation dynamics play a crucial role in modulating its reactivity in different solvents.

SC 51322

146032-79-3sc-361351
sc-361351A
10 mg
50 mg
$135.00
$595.00
(0)

SC 51322, classified as an EP1 compound, showcases intriguing reactivity patterns attributed to its acid halide structure. The presence of a highly electrophilic carbonyl group enables swift acylation processes, promoting diverse nucleophilic attacks. Its unique steric hindrance influences reaction pathways, resulting in selective product formation. Additionally, SC 51322 demonstrates notable interactions with metal catalysts, enhancing its utility in various synthetic transformations. The compound's solubility characteristics further impact its reactivity, making it a versatile participant in chemical reactions.

SC 19220

19395-87-0sc-203450B
sc-203450C
sc-203450
sc-203450A
1 mg
5 mg
10 mg
50 mg
$22.00
$104.00
$184.00
$797.00
2
(0)

SC 19220, an EP1 compound, exhibits remarkable reactivity due to its acid halide nature. The compound's electrophilic carbon center facilitates rapid acyl transfer, allowing for efficient coupling with nucleophiles. Its distinct steric environment can modulate reaction kinetics, leading to regioselective outcomes. Furthermore, SC 19220's ability to form stable complexes with Lewis acids enhances its reactivity profile, making it a key player in various synthetic pathways.

8-Chloro-dibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid 2-[3-[(2-furanylmethyl)thio]-1-oxopropyl]hydrazide

146032-79-3sc-205848
sc-205848A
5 mg
25 mg
$77.00
$312.00
(0)

8-Chloro-dibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid 2-[3-[(2-furanylmethyl)thio]-1-oxopropyl]hydrazide, an EP1 compound, showcases unique molecular interactions due to its intricate structure. The presence of the furan moiety introduces distinct electronic effects, influencing nucleophilic attack patterns. Its hydrazide functionality enhances hydrogen bonding capabilities, promoting solubility in polar solvents and facilitating diverse reaction mechanisms. This compound's intricate sterics and electronics enable selective reactivity in complex synthetic environments.

GW 848687X

612831-24-0sc-295034
sc-295034A
500 µg
1 mg
$147.00
$279.00
(0)

GW 848687X, an EP1 compound, exhibits remarkable reactivity as an acid halide, characterized by its ability to form stable acyl derivatives through nucleophilic acyl substitution. The presence of halogen atoms enhances electrophilicity, facilitating rapid reactions with amines and alcohols. Its unique steric configuration allows for selective interactions, while the compound's polar nature promotes solvation effects, influencing reaction kinetics and pathways in various chemical environments.

L-798,106

244101-02-8sc-204047
sc-204047A
5 mg
25 mg
$103.00
$409.00
16
(1)

L-798106 is a selective EP1 antagonist that directly inhibits EP1 receptor activation. It competes with PGE2 for binding to EP1, interfering with downstream signaling cascades. By blocking EP1, L-798106 modulates cellular responses influenced by EP1, including smooth muscle contraction and pain sensation. The compound′s specificity for EP1 highlights its utility in dissecting the intricate roles of EP1 in various physiological and pathological processes.

MK-7246

1218918-62-7sc-484140
2.5 mg
$550.00
(0)

MK-7246 is a selective EP1 antagonist that directly inhibits EP1 signaling. It competes with PGE2 for binding to EP1, disrupting the downstream signaling events initiated by EP1 activation. By blocking EP1, MK-7246 modulates cellular responses influenced by EP1, such as vascular tone and inflammation. This compound′s specificity for EP1 makes it a valuable tool for studying the distinct functions of EP1 in different cellular contexts.